+37.0%
MSTR vs CVS
+11.5%
+25.5%
-82.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.7% | -0.9% | -6.8% | -7.5% |
| 7D | -18.0% | +3.9% | -21.9% | -18.7% |
| 30D | -24.7% | -3.4% | -21.3% | -24.5% |
| 3M | +10.7% | -8.2% | +18.9% | +12.2% |
| 6M | -41.9% | -6.4% | -35.6% | -41.8% |
| YTD | -32.2% | +15.1% | -47.3% | -37.4% |
| 1Y | -48.4% | +17.4% | -65.8% | -52.8% |
| 3Y | +110.7% | +45.3% | +65.3% | +69.6% |
| 5Y | +37.0% | +12.7% | +24.3% | +52.8% |
| All | +37.0% | +11.5% | +25.5% | +52.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling